Changes in regional brain metabolism following aromatase inhibitor therapy in postmenopausal women

被引：0
|
作者：
Silverman, Daniel [1 ]
Lee, Soo [1 ]
Geist, Cheri [1 ]
Yang, Chine Ching [1 ]
Togawa, Kayo [2 ]
Katheria, Vani [2 ]
Hansen, Kurt [2 ]
Patel, Sunita [2 ]
Czernin, Johannes [1 ]
Hurria, Arti [2 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2010年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1803
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Changes in regional brain metabolism following initial therapy for breast cancer
    Pomykala, Kelsey
    Geist, Cheri
    Silverman, Daniel
    Kwan, Lorna
    Bower, Julienne
    Irwin, Michael
    Czernin, Johannes
    Phelps, Michael
    Ganz, Patricia
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [2] Sexual Dysfunction in Postmenopausal Women with Breast Cancer on Adjuvant Aromatase Inhibitor Therapy
    Lubian Lopez, Daniel Maria
    Butron Hinojo, Carmen Aisha
    Sanchez-Prieto, Manuel
    Mendoza, Nicolas
    Sanchez-Borrego, Rafael
    BREAST CARE, 2021, 16 (04) : 376 - 382
  • [3] Role function in postmenopausal women during aromatase inhibitor therapy for breast cancer
    Melnyk, Halia
    Dickson, Victoria Vaughan
    Bender, Catherine
    Yu, Gary
    Djukic, Maja
    Merriman, John
    JOURNAL OF CANCER SURVIVORSHIP, 2024,
  • [4] CHANGES IN BONE DENSITY OVER 1 YEAR OF AROMATASE INHIBITOR THERAPY IN WOMEN WITH POSTMENOPAUSAL BREAST CANCER AND OSTEOPENIA
    Taxel, Pamela
    Bansal, Renu
    Mirza, Faryal
    Hawli, Yousra
    Tannenbaum, Susan
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S220 - S220
  • [5] Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD
    Silverman, Daniel H. S.
    Geist, Cheri L.
    Kenna, Heather A.
    Williams, Katherine
    Wroolie, Tonita
    Powers, Bevin
    Brooks, John
    Rasgon, Natalie L.
    PSYCHONEUROENDOCRINOLOGY, 2011, 36 (04) : 502 - 513
  • [6] Changes in lipid-levels following aromatase inhibitor treatment in early postmenopausal breast cancer
    Lund, M.
    Corn, G.
    Jensen, M-B.
    Petersen, T. S.
    Dalhoff, K.
    Ejlertsen, B.
    Kober, L.
    Wohlfahrt, J.
    Melbye, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S341 - S341
  • [7] Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy
    Dieckmeyer, Michael
    Ruschke, Stefan
    Rohrmeier, Alexander
    Syvaeri, Jan
    Einspieler, Ingo
    Seifert-Klauss, Vanadin
    Schmidmayr, Monika
    Metz, Stephan
    Kirschke, Jan S.
    Rummeny, Ernst J.
    Zimmer, Claus
    Karampinos, Dimitrios C.
    Baum, Thomas
    BMC MUSCULOSKELETAL DISORDERS, 2019, 20 (01)
  • [8] Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy
    Michael Dieckmeyer
    Stefan Ruschke
    Alexander Rohrmeier
    Jan Syväri
    Ingo Einspieler
    Vanadin Seifert-Klauss
    Monika Schmidmayr
    Stephan Metz
    Jan S. Kirschke
    Ernst J. Rummeny
    Claus Zimmer
    Dimitrios C. Karampinos
    Thomas Baum
    BMC Musculoskeletal Disorders, 20
  • [9] Adherence to Adjuvant Aromatase Inhibitor Therapy Among Postmenopausal Hispanic/Latino Women With Breast Cancer
    Philipovskiy, Alexander
    Campbell, Aleli
    Heydarian, Rosalinda
    Castillo, Brenda
    Dwivedi, Alok K.
    Mccallum, Richard
    Aguilera, Renato
    Gaur, Sumit
    Nahleh, Zeina
    ANTICANCER RESEARCH, 2020, 40 (02) : 857 - 864
  • [10] Aromatase inhibitor therapy for uterine bleeding in a postmenopausal woman with leiomyomata
    Kaunitz, Andrew M.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (05): : 941 - 943
12345